![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Innosis Ecological Ag | TG:IVX | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
BW20030421002004 20030422T060040Z UTC ( BW)(IVAX-CORPORATION)(IVX) Directorate Change Business Editors UK REGULATORY NEWS MIAMI--(BUSINESS WIRE)--April 22, 2003-- IVAX Nominates 2003 Directors; Includes Three New Independent Directors IVAX Corporation (AMEX:IVX)(LSE:IVX.L) announced today the nominees to its board of directors for elections to be held at the 2003 annual meeting of shareholders. The slate includes eight incumbent directors and three additional independent directors. The incumbent directors nominated are: Phillip Frost, M.D., Neil Flanzraich, Jane Hsiao, Ph.D., Mark Andrews, Ernst Biekert, Ph.D., Jack Fishman, Ph.D., Richard Pfenniger, Jr. and David Lieberman. The three additional independent director nominees are: Betty G. Amos, CPA, is the owner and president of The Abkey Companies, a franchisee of Fuddruckers restaurants. Ms. Amos holds both Bachelor and Masters of Business Administration degrees from the University of Miami and has served on the University of Miami board of trustees since 1997, including two years as Chair of the audit committee. In 1993, The National Association of Women Business Owners recognized her as their Outstanding Woman Business Owner. Modesto A. (Mitch) Maidique, Ph.D., is the President of Florida International University. During his 17-year tenure at FIU, Dr. Maidique has presided over the establishment of the Schools of Architecture, Computer Science, Music and Law, more than doubling FIU's enrollment to over 34,000 students. Dr. Maidique holds a Ph.D. from the Massachusetts Institute of Technology, is a graduate of the Harvard Business School, and has taught at MIT, Harvard and Stanford Universities. He serves on the boards of National Semiconductor and Carnival Corporations and is a past chairman of The Beacon Council, Miami's economic development authority. Bertram Pitt, M.D. has been a Professor of Internal Medicine at the University of Michigan School of Medicine since 1977, where he also served as the Director of the Division of Cardiology from 1977 to 1991 and as Associate Chairman for Academic and Industrial Programs from 1991 to 1999. Dr. Pitt was elected to the Johns Hopkins University Society of Scholars in 2000, received the Forest Dewey Dodrill Award for Excellence from the American Heart Association in 2001 and the Paul Dekruif Lifetime Achievement Award from the University of Michigan in 2002. IVAX also announced that Isaac Kaye will not stand for re-election to the IVAX board and at the conclusion of the company's 2003 annual meeting will retire as IVAX' Deputy Chief Executive Officer and Chief Executive Officer of the UK division, positions he has held since 1990. Charles M. Fernandez will also not stand for re-election to the board in order to devote more time to new business ventures. Mr. Fernandez has served as a director since 1998. Phillip Frost, M.D., chairman and chief executive officer of IVAX said, "The board of directors has accepted Mr. Kaye's decision to retire after a long and distinguished career at IVAX. The board of directors and the entire IVAX community thank Mr. Kaye for his many years of dedicated leadership in the company. Charles Fernandez is also departing from our board; he has served us well. We are all grateful for their many contributions." Frank Condella, who joined IVAX last August as Managing Director in the UK, will continue to direct IVAX' activities there, as well as oversee other European operations. IVAX Corporation, headquartered in Miami, Florida, discovers, develops, manufactures, and markets branded and brand equivalent (generic) pharmaceuticals and veterinary products in the U.S. and internationally. Copies of this and other news releases may be obtained free of charge from IVAX' website at http://www.ivax.com. Short Name: IVAX Corporation Category Code: BOA Sequence Number: 00004141 Time of Receipt (offset from UTC): 20030418T220231+0100 --30--CK/ny* CONTACT: IVAX Corporation Jim Whitlow, 305/575-6043 KEYWORD: FLORIDA UNITED KINGDOM INTERNATIONAL EUROPE INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL MANAGEMENT CHANGES SOURCE: IVAX Corporation Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: http://www.businesswire.com
1 Year Innosis Ecological Chart |
1 Month Innosis Ecological Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions